Nanobio : Projet Nano Biotechnologie Grenoble Isère
Speakers
Dr. Peter Wick
Dr. rer. nat. Dipl Biologe (14.09.1971)
Position:
Group leader NanoInterCell at Laboratory for Materials – Biology Interactions,
Empa Swiss Federal Laboratories for Materials Testing and Research
Education:
- 1994 – 1998 study of cell- and molecular biology at the University of Fribourg (CH)
- 1998 – 2002 PhD at the University of Fribourg in Prof Dr Jean-Pierre Métraux’ group
- At the time: further training for human toxicology
Activity:
2002 - 04 scientific collaborator at the Empa St. Gallen (CH) in the Materials – Biology Interactions Lab. In the beginning the study of the interaction of cell – implant materials and tissue engineering was the major focus.
2004 - 08 project leader in nanotoxicology of a national project ‘NanoRisk’ and responsible for work-package ‘Nanotox’ in the European integrated project CANAPE.
Since 2009 group leader of the Nanointercell Group
Kontakt:
Dr. Peter Wick
EMPA Swiss Federal Laboratories for Material Testing and Research
Laboratory for Materials - Biology Interaction
Lerchenfeldstr. 5 -
CH-9014 St.Gallen
Phone: +41 (0)71 274 76 84
Web: http://www.empa.ch/abt274
Mail: peter.wick@empa.ch
Recent publications:
Belyanskaya L, Weigel S, Hirsch C, Tobler U, Krug HF, Wick P, Effect of carbon nanotubes on primary neuronal and glial cells (submitted)
Wick P, Su D, Kaiser JP, Maeder-Althaus X, Weinberg G, Thurnherr T, Pfänder N, Arrigo R, Manser P, Bruinink A. Exposure of human lung cells to industrial scale produced multi walled carbon nanotubes: effects on cell physiology in vitro (submitted).
Kaiser JP, Krug HF, Wick P, (2008) Nanomaterial cell interactions: how carbon nanotubes affect cell physiology Nanomedicine (4)1 57-63
Spohn P, Hirsch C, Halser F, Bruinink A, Krug HF, Wick P, (2008) C60 fullerene a powerful antioxidant or a damaging agent? The importance of an in-depth material characterization prior to toxicity assays Environ Pull, doi:10.1016/J.envpol.2008.08.013
Helfenstein M, Miragoli M, Rohr S, Müller L, Wick P, Mohr M, Gehr P, Rothen-Ruthishauser B, (2008) Effects of combustion-derived ultrafine particles and manufactured nanoparticles on heart cells in vitro, Toxicology, doi:10.1016/j.tox.2008.08.018
Kaiser JP, Wick P, Manser, Spohn P, Bruinink A, (2007) Single walled carbon nanotubes (SWCNT) affect cell physiology and cell architecture, J Mater Sci: Mater Med, accepted
Belyanskaya L, Manser P, Spohn P, Bruinink A, Wick P, (2007) The reliability and limits of the MTT conversion test for carbon nanotubes – cell interaction, Carbon, 45, 2643-48
Helland A, Wick P, Som C, Köhler A, Schmied K, Bruinink A, (2007) Risk assessement of carbon nanotubes: An insight into the scientific literature & discussion, Environ Health Perspect 115 (8) 1125-31
Limbach L, Wick P, Manser P, Grass RN, Bruinink A, Stark WJ, (2007) Exposure of engineered nanoparticles to human lung epithelial cells: Influence of chemical composition and catalytic activity on oxidative stress, Environ Sci Technol, 41, 11, 4158-63
Wick P, Kaiser JP, Manser P, Spohn P, Bruinink A, (2007) The presence of carbon nanotubes affect cell physiology and interfeers with cell adhesion. Proceedings Viennano 07 ISBN 978-3-901657-25-1, 119-124
Wick P, Manser P, Limbach LK, Dettlaff-Weglikowska U, Krumeich F, Roth S, Stark WJ, Bruinink A, (2007) The degree and kind of agglomeration affect carbon nanotube cytotoxicity, Toxicology letters, 168, 121-131
Wick P, Manser P, Spohn P, Bruinink A, (2006) In vitro evaluation of possible adverse effect of nanosized materials, Physica Status Solidi b 243(13)3556-60
Brunner TJ, Wick P, Manser P, Spohn P, Grass RN, Limbach LK, Bruinink A, Stark WJ (2006) In vitro cytotoxicity of oxide nanoparticles: comparison to asbestos, silica and the effect of particle solubility Environ Sci Technol 40(14), 4374-81